FUSION PROTEIN COMPRISING TARGETING PEPTIDE OF CD13 AND LIDAMYCIN
摘要
Provided is a fusion protein NGR-LDP-AE, which comprises targeting peptide of CD13, lidamycin apoprotein LDP and activated form enediyne chromophore AE combined with the LDP. This fusion protein can be used for targeted cancer therapy.
申请公布号
WO2008145013(A8)
申请公布日期
2009.07.30
申请号
WO2008CN01014
申请日期
2008.05.26
申请人
INSTITUTE OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES;ZHENG, YANBO;ZHEN, YONGSU;SHANG, BOYANG;LIU, XIUJUN;WU, SHUYING
